Session # P073
Presenting Author: Victoria Ellis, MS, CGC
Take home points:
- This is the largest TMEM127 PV cohort reported to date.
- Results support the association of TMEM127 with PGL/PCC and provide quantifiable odds of tumor frequency compared to a similarly selected cohort that is negative for PV in known PCC/PGL genes. We found a significant OR for TMEM127+ heterozygotes for PCC (OR=31.49, p<0.001), and an OR approaching significance for PGL (OR=5.8, p=0.058).
- Further studies on PGL, kidney, glioblastoma, and other tumor associations are needed to inform consensus surveillance guidelines.
- Authors: Victoria Ellis; June Mikkelson; Jeni Herrera-Mullar; Jamie Weyandt; Colin Young; Brittany Sears
- Conference:
ACMG 2026
- Date: Thursday, Mar 12, 2026 10:30am - 11:30am